Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Dual-payload antibody-drug conjugate for chemo-immunotherapy of triple-negative breast cancers
Liu, X. X. M. (PI) & Carson, W. E. (CoPI)
07/25/23 → 06/30/26
Project: Research
-
OSU K12 Training Grant in Oncology
Carson, W. E. (CoPI), Byrd, J. C. (CoPI) & Lapalombella, R. (CoPI)
09/9/08 → 06/30/26
Project: Research
-
Clinical Protocol and Data Management
Carson, W. E. (PI) & Carson, W. W. E. (PI)
12/1/20 → 11/30/23
Project: Research
-
OSU as a Network Lead Academic Participating Site for the NCI NCTN
Verschraegen, C. (PI), Chakravarti, A. (CoPI), Carbone, D. P. (CoPI), O'Malley, D. M. (CoPI) & Carson, W. E. (CoPI)
03/28/19 → 02/28/25
Project: Research
-
Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment
Guo, P. (PI), Carson, W. E. (CoPI), Pack, D. W. (CoPI) & Yu, J. (CoPI)
09/26/16 → 08/31/21
Project: Research
-
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based study
Lesinski, J. D., Yi, J., Ghias, E., Fisher, J. L., Baker, M. G., Llanos, A. A. M., Rogers, C. R., Quist, A. J. L., Felix, A., Paskett, E. D., Elsaid, M. I., Richardson, D., Hajat, A., Sundi, D., Eisfeld, A. K., Rosko, A. E., Pawlik, T., Obeng-Gyasi, S., Cruz-Monserrate, Z. & Carson, W. E. & 2 others, , Jan 2026, In: The Lancet Oncology. 27, 1, p. 79-89 11 p.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial
Kendra, K. L., Bellasea, S. L., Eroglu, Z., Hu-Lieskovan, S., Campbell, K. M., Carson, W. E., Wada, D. A., Plaza, J. A., In, G. K., Ikeguchi, A., Hyngstrom, J., Brohl, A. S., Chmielowski, B., Khushalani, N. I., Markowitz, J., Monroe, M., Contreras, C. M., Bowles, T., Norman, K. & Medina, E. & 13 others, , Feb 2026, In: Nature Cancer. 7, 2, p. 272-282 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance)
Liu, A., Johnson, C., Niedzwiecki, D., Relation, T., Yarlagadda, S. V., Gajewski, T. F. & Carson, W. E., Mar 1 2026, In: Cancer immunology research. 14, 3, p. 423-433 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockade
Angell, C. D., Sun, S. H., Lapurga, G., Benner, B., Quiroga, D., Savardekar, H., Divincenzo, M. J., Abood, D., Stiff, A., Duggan, M., Handley, D., Nagle, E., Howard, J. H., Shah, H., Kendra, K. L. & Carson, W. E., Apr 1 2025, In: Melanoma research. 35, 2, p. 102-108 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial
Kendra, K. L., Bellasea, S. L., Eroglu, Z., Hu-Lieskovan, S., Campbell, K. M., Carson, W. E., Wada, D. A., Plaza, J. A., Sosman, J. A., In, G. K., Ikeguchi, A., Hyngstrom, J., Brohl, A. S., Khushalani, N. I., Markowitz, J., Negrea, G., Kasbari, S., Doolittle, G. C., Swami, U. & Roberts, T. & 13 others, , Nov 2025, In: Nature Medicine. 31, 11, p. 3668-3674 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations